New anti-viral drugs for the treatment of COVID-19 instead of favipiravir
Ahmet Hamdi AktaşFaculty of Medicine, Department of Internal Medicine, Sivas Cumhuriyet University, Sivas, TurkeyBurak TüzünFaculty of Science, Department of Chemistry, Sivas Cumhuriyet University, Sivas, TurkeyRukiye AslanMedical Services and Techniques Department, Vocational School of Health Services, Sivas Cumhuriyet University, Sivas, TurkeyKoray SayınAdvanced Technology Research and Application Center, Sivas Cumhuriyet University, Sivas, TurkeyHilmi AtasevenFaculty of Medicine, Department of Gastroenterology, Sivas Cumhuriyet University, Sivas, Turkey
2020en
ABI
Annotatsiya
-pyrazine-3-carboxamide performed better than favipiravir in the results of molecular docking, molecular mechanics Poisson-Boltzmann surface area (MM-PSBA) calculations, and ADME analyses.Communicated by Ramaswamy H. Sarma.
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba